Drugs@FDA document
LUPRON DEPOT Letter · NDA 020517 SUPPL-43
Drugs@FDA document · ABBVIE ENDOCRINE INC · Apr 19, 2022
Key facts
| Drug name | LUPRON DEPOT |
|---|---|
| Document type | Letter |
| Application | NDA020517 |
| Submission | SUPPL-43 |
| Company | ABBVIE ENDOCRINE INC |
| Document date | Apr 19, 2022 |
At a glance
- Efficacy-New Indication Document categories
- 10–99 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: